Sofosbuvir and Velpatasvir combination is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection-
Without cirrhosis or with compensated cirrhosis
With decompensated cirrhosis for use in combination with ribavirin